CBD Class-Action Litigants Watching For Retroactive Effects In US FDA’s Awaited Rulemaking

Even in the “highly unlikely event” that the FDA does make CBD supplements legal, it will not do so retroactively, according to plaintiffs against CV Sciences in California’s Central District. However, the federal court, which also is hearing a similar case against competitor Charlotte’s Web, is not convinced.